NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death.
SOURCE: NIH News Releases – Read entire story here.
Related posts:
- Five perspectives on HIV prevention pill awaiting Australian approval Australia's ambitious goal of no new cases of HIV by 2020 will be a tough deadline to meet given rates have been steadily increasing since 2000. Here, the ABC hears five perspectives on a major breakthrough in the fight against the epidemic — the preventative drug known as PrEP. ...
- Governments take decisive step towards more affordable vaccines Governments meeting in Geneva for the annual World Health Assembly raised the alarm on Monday over the exorbitant rise in the price to vaccinate a child, passing a resolution urging more affordable... ...
- Combining targeted drug with chemotherapy offers longer life to b-cell cancer patients Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia or small lymphocytic lymphoma, an interim analysis has closed the international HELIOS phase III clinical trial. ...
- UK population is becoming overweight and obese at younger ages Children born since the 1980s are two to three times more likely than older generations to be overweight or obese by the age of 10, according to new research. The study characterized population shifts in body mass index using data from more than 56,000 people born in Britain from 1946 to 2001. ...
- Insights into Energy-Burning Fat Cells Insights into Energy-Burning Fat CellsResearchers identified beige fat cells, which burn energy rather than store it, in humans. The finding may lead to new ways to engineer fat cells to fight obesity. ...
